AC Immune ACIU
NASDAQ ACIU
$2.49 +0.06 (+2.26%)
At close: Oct 20, 2026 · 4:00 PM EDT

AC Immune (ACIU) Notes Payables (2018 - 2019)

Updated

AC Immune's Notes Payables was $336,773 in the quarter ended Sep 30, 2020, down 0.7% from $338,994 a year earlier but up 1.1% from the prior quarter.

Analysis

AC Immune (ACIU) Notes Payables (2018 - 2019) Analysis & Trends

As of Dec 31, 2019, Notes Payables at AC Immune came in at $656,409, up 93.3% from the prior year.

  • In earlier years, Notes Payables was $339,540 in the year ended Dec 31, 2018.
  • Quarterly Notes Payables has moved between $333,138 (the quarter ended Jun 30, 2020) and $658,770 (the quarter ended Dec 31, 2019) over five years.
  • Per Business Quant data, ACIU's Notes Payables in the three quarters before the quarter ended Sep 30, 2020 was $333,138 (quarter ended Jun 30, 2020), $334,966 (quarter ended Mar 31, 2020) and $658,770 (quarter ended Dec 31, 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 AC Immune 250.37 Mn -188.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 337,067.34
Jun 30, 2019 336,865.82
Mar 31, 2019 337,746.13
Dec 31, 2018 337,535.58
API Access

AC Immune Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=ACIU&period=max&api_key=YOUR_API_KEY